Area of research
Infectious Diseases · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cystic Fibrosis Research Advances, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, and COVID-19 Impact on Reproduction.
Unique nasal cell states induced by common pediatric respiratory viruses
Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials
Targeting the SARS-CoV-2 reservoir in long COVID
TGFβ links EBV to multisystem inflammatory syndrome in children
TGFβ links EBV to multisystem inflammatory syndrome in children.
Heterogeneity in Reported Side Effects Following Initiation of Elexacaftor-Tezacaftor-Ivacaftor: Experiences at a Quaternary CF Care Center.
Viral spike antigen clearance and augmented recovery in children with post-COVID multisystem inflammatory syndrome treated with larazotide.
MONOCYTE ANISOCYTOSIS IS ASSOCIATED WITH SEPSIS IN CHILDREN WITH SUSPECTED INFECTION.
NorA and Tet38 efflux pumps enable <i>Staphylococcus aureus</i> survival in the cystic fibrosis airway environment, resistance to antibiotics, and coinfection with <i>Pseudomonas aeruginosa</i>.
Monocyte Anisocytosis Changes in Patients After Major Burn Injuries.
Resolvin D2 restores monocyte anisocytosis and mediates a shift toward classical monocytes ex vivo in blood samples from patients after major burns.
"How Do You Live the Best Life You Can With This Pain?" A Qualitative Study of Adults Living With CF and Pain in the Modulator ERA.
Illness Burden in Adults With Cystic Fibrosis: Associations With Sex, Race/Ethnicity, and Socioeconomic Risk Factors.
Severe Bleomycin-Induced Pneumonitis Following Localized Injection in a Child with a TERT Variant and Short Telomeres
Quantification of fibrinaloid clots in plasma from pediatric Long COVID patients using a microfluidic assay
Enhanced placental antibody transfer efficiency with longer interval between maternal respiratory syncytial virus vaccination and birth
Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination.
Gain-of-function variants in SMAD4 compromise respiratory epithelial function
Palliative care needs among outpatient adults with cystic fibrosis: Baseline data from the Improving Life with CF trial
COVID-19 in Pediatric Populations
COVID-19 mRNA Vaccines Induce Robust Levels of IgG but Limited Amounts of IgA Within the Oronasopharynx of Young Children.
Validation of the Integrated Palliative Care Outcome Scale (IPOS) in adults with cystic fibrosis.
Depths of Dysfunctional Epithelial and Immune Crosstalk in Cystic Fibrosis Revealed.
COVID-19 mRNA vaccines induce robust levels of IgG but limited amounts of IgA within the oronasopharynx of young children
Heterogeneity in Reported Side Effects Following Initiation of Elexacaftor-Tezacaftor-Ivacaftor: Trikafta Experiences at a Quaternary CF Care Center
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).
Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis.
Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort